Surely this is an impoortant question to be asking of KNL. If they are no longer financing, why wasn't this reported? Surely this is price sensitive.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025